![Lars Mecklenburg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Mecklenburg
Chief Executive Officer at Labcorp Early Development Services GmbH
Profile
Lars Mecklenburg is currently the Co-Managing Director at Labcorp Early Development Services GmbH since 2019.
Prior to this, he worked as the Vice President-Clinical Operations at Indivumed GmbH.
Dr. Mecklenburg obtained a doctorate degree from the University of Hannover.
Lars Mecklenburg active positions
Companies | Position | Start |
---|---|---|
Labcorp Early Development Services GmbH
![]() Labcorp Early Development Services GmbH Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Labcorp Early Development Services GmbH is a contract research organization (CRO) that provides drug development services with the goal of advancing health. The company is based in Muenster, Germany. Labcorp Early Development Services offers thousands of in vitro tests and in vivo studies in various disciplines such as toxicology, metabolism, pharmacology, pharmacometric modeling, custom antibodies, vaccine development, infusion, inhalation, ocular, as well as disease models for oncology and cardiovascular. The German company provides SEND 3.1 datasets on the same day as the final report and can customize studies based on development milestones. With facilities worldwide, Labcorp Early Development Services helps pharmaceutical and biotechnology companies reach their development milestones more quickly and efficiently. The company's mission is to improve health and improve lives. Founded in 1981, the CEOs of the company are Glenn Andrew Eisenberg, Lars Mecklenburg, and Robert Stewart Pringle. | Chief Executive Officer | 26/06/2019 |
Former positions of Lars Mecklenburg
Companies | Position | End |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Chief Tech/Sci/R&D Officer | - |
Training of Lars Mecklenburg
University of Hannover | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
Labcorp Early Development Services GmbH
![]() Labcorp Early Development Services GmbH Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Labcorp Early Development Services GmbH is a contract research organization (CRO) that provides drug development services with the goal of advancing health. The company is based in Muenster, Germany. Labcorp Early Development Services offers thousands of in vitro tests and in vivo studies in various disciplines such as toxicology, metabolism, pharmacology, pharmacometric modeling, custom antibodies, vaccine development, infusion, inhalation, ocular, as well as disease models for oncology and cardiovascular. The German company provides SEND 3.1 datasets on the same day as the final report and can customize studies based on development milestones. With facilities worldwide, Labcorp Early Development Services helps pharmaceutical and biotechnology companies reach their development milestones more quickly and efficiently. The company's mission is to improve health and improve lives. Founded in 1981, the CEOs of the company are Glenn Andrew Eisenberg, Lars Mecklenburg, and Robert Stewart Pringle. | Health Services |
- Stock Market
- Insiders
- Lars Mecklenburg